Most Read News

AVT03 has been developed as a biosimilar to denosumab, the active ingredient used in Prolia and Xgeva.

IIT Chennai will lead the fundamental and conceptual design phase and focus on developing advanced technologies and intellectual property that address complex defence requirements.

The order underlines the expansion and modernisation of Gauhati Medical College & Hospital in Guwahati.

With this new capacity, the company could be able to boost its ability to serve rapidly accelerating markets across Eastern and Central India.

Overall, the week witnessed amongst the highest equity inflows in ten weeks, indicating a shift toward equities amid supportive macro cues.

This includes legacy infrastructure, siloed data, regulatory complexities, and the need for sustainable and scalable modernisation.

The Power Purchase Agreement (PPA) will be signed directly between the Indian Railways and winning bidders, with no intermediary involved.

The floor price for this transaction has been fixed at ₹2,096.70 per share. This is at a discount of 3% to Bharti Airtel’s closing price of ₹2,161.60.

The approved product is a biosimilar of the US reference listed drug Calan SR extended-release tablets in the same vials.

HDFC AMC announced the issue of one bonus share for every one share held by eligible shareholders as on the record date.